Related Experiment Video
Updated: Jun 6, 2026

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
Facial palsy: etiology, outcome and management in children
Andreas Christoph Jenke1, Lisa-Marie Stoek, Matthias Zilbauer
1Children's Hospital, HELIOS Klinikum Wuppertal, Witten-Herdecke University, Heusnerstr. 40, D-42283 Wuppertal, Germany. andreas.jenke@helios-kliniken.de
Insights
Most children with facial palsy recover spontaneously, especially younger ones and those with neuroborreliosis. Corticosteroid treatment is not routinely recommended for pediatric facial palsy due to high spontaneous recovery rates.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
Background:
- Controversy exists regarding corticosteroid use for idiopathic facial palsy in children.
- Limited data available on the natural disease progression in pediatric cases.
Purpose of the Study:
- To investigate the natural course and recovery rates of facial palsy in children.
- To evaluate the efficacy of symptomatic treatment versus antibiotic therapy in specific cases.
Main Methods:
- Prospective study of children under 15 with facial palsy (1998-2008).
- Standardized diagnostic work-up and follow-up protocols were applied.
- Treatment included symptomatic care, with intravenous antibiotics for neuroborreliosis.
Main Results:
- 106 pediatric patients were analyzed.
- Overall complete recovery rate was 97.6%.
- Younger children and those with neuroborreliosis showed faster recovery.
Conclusions:
- High spontaneous recovery rate (97.6%) suggests corticosteroids are not routinely necessary for pediatric facial palsy.
- Further controlled trials are needed to definitively establish treatment guidelines.
Background:
Currently there is much controversy whether to treat idiopathic facial palsy with corticosteroids with sparse data on the natural course of the disease in children.
Methods:
We performed a prospective study on all children <15 years of age who were admitted to our unit for facial palsy between 1st July 1998 to 30th June 2008. All patients received a standardized work-up and follow-up. Therapy consisted of symptomatic treatment either with (in case of neuroborreliosis) or without a 14 day course of intravenous antibiotics.
Findings:
106 patients were included in our study. The calculated incidence for facial palsy was 21.1/100000/year for children <15 years. The incidence for neuroborreliosis (NB) in this age group was calculated to be 4.9/100000/year. The overall rate of complete recovery was 97.6% with significantly faster recovery in younger children and in patients with NB as compared to idiopathic facial palsy. Both patients with incomplete recovery were at least 14 years old and presented late in the course of the disease.
Conclusion:
Based on the rate of 97.6% spontaneous complete recovery we believe that the routine use of corticosteroids in children with facial palsy is not justified, unless there is new data from controlled trials in children.
Related Concept Videos
Botulism
Prosopagnosia
Cardiopulmonary Resuscitation II: ACLS Airway Management
Muscles for Facial Expressions
